240 related articles for article (PubMed ID: 3111844)
21. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy.
Lundgren CH; Sawa H; Sobel BE; Fujii S
Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha regulates mRNA for urokinase-type plasminogen activator and type-1 plasminogen activator inhibitor in human neoplastic cell lines.
Georg B; Helseth E; Lund LR; Skandsen T; Riccio A; Danø K; Unsgaard G; Andreasen PA
Mol Cell Endocrinol; 1989 Jan; 61(1):87-96. PubMed ID: 2501120
[TBL] [Abstract][Full Text] [Related]
23. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
[TBL] [Abstract][Full Text] [Related]
24. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C; Kruithof EK; Schleuning WD
J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
[TBL] [Abstract][Full Text] [Related]
25. Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts.
Graham CH
Placenta; 1997; 18(2-3):137-43. PubMed ID: 9089774
[TBL] [Abstract][Full Text] [Related]
26. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.
Laiho M; Saksela O; Andreasen PA; Keski-Oja J
J Cell Biol; 1986 Dec; 103(6 Pt 1):2403-10. PubMed ID: 3491081
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-beta modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro.
Wikner NE; Elder JT; Persichitte KA; Mink P; Clark RA
J Invest Dermatol; 1990 Nov; 95(5):607-13. PubMed ID: 2230225
[TBL] [Abstract][Full Text] [Related]
28. Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells.
Wileman SM; Booth NA; Moore N; Redmill B; Forrester JV; Knott RM
Br J Ophthalmol; 2000 Apr; 84(4):417-22. PubMed ID: 10729302
[TBL] [Abstract][Full Text] [Related]
29. Multiple transforming growth factor-beta-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells.
Westerhausen DR; Hopkins WE; Billadello JJ
J Biol Chem; 1991 Jan; 266(2):1092-100. PubMed ID: 1985937
[TBL] [Abstract][Full Text] [Related]
30. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
Konkle BA; Ginsburg D
J Clin Invest; 1988 Aug; 82(2):579-85. PubMed ID: 3136192
[TBL] [Abstract][Full Text] [Related]
31. Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells.
Jakowlew SB; Mariano JM; You L; Mathias A
Biochim Biophys Acta; 1997 Aug; 1353(2):157-70. PubMed ID: 9294010
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta 1 modulation of urokinase and PAI-1 expression in human bronchial epithelial cells.
Gerwin BI; Keski-Oja J; Seddon M; Lechner JF; Harris CC
Am J Physiol; 1990 Oct; 259(4 Pt 1):L262-9. PubMed ID: 2221087
[TBL] [Abstract][Full Text] [Related]
33. Specific induction of secreted proteins by transforming growth factor-beta and 12-O-tetradecanoylphorbol-13-acetate. Relationship with an inhibitor of plasminogen activator.
Thalacker FW; Nilsen-Hamilton M
J Biol Chem; 1987 Feb; 262(5):2283-90. PubMed ID: 2434480
[TBL] [Abstract][Full Text] [Related]
34. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
[TBL] [Abstract][Full Text] [Related]
35. Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis.
Feng L; Tang WW; Loskutoff DJ; Wilson CB
J Am Soc Nephrol; 1993 May; 3(11):1753-64. PubMed ID: 8329670
[TBL] [Abstract][Full Text] [Related]
36. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
[TBL] [Abstract][Full Text] [Related]
38. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
39. PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.
Rougier JP; Guia S; Hagège J; Nguyen G; Ronco PM
Kidney Int; 1998 Jul; 54(1):87-98. PubMed ID: 9648067
[TBL] [Abstract][Full Text] [Related]
40. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
